Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Vutrisiran be approved by the European Medicines Agency by October 31, 2025?  | Binary | 4 | 2 months ago | ||
Will Vutrisiran achieve multibillion-dollar sales by end of 2026? | Binary | 4 | 2 months ago | ||
Will diagnosis rates for ATTR amyloidosis with cardiomyopathy increase by end of 2025? | Binary | 2 | 2 months ago | ||
What will be the outcome of Vutrisiran's regulatory application to the European Medicines Agency by October 31, 2025? | Categorical | 2 | 2 months ago | ||
Who will be the leading competitor to Vutrisiran in the ATTR amyloidosis market by end of 2025? | Categorical | 2 | 2 months ago | ||
What will be Alnylam Pharmaceuticals' rank among biotech companies by market cap by end of 2025? | Categorical | 2 | 2 months ago |